Wells Fargo’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468 | Sell |
323
-19,892
| -98% | -$28.8K | ﹤0.01% | 5916 |
|
|
2025
Q1 | $27.9K | Buy |
20,215
+675
| +3% | +$932 | ﹤0.01% | 5145 |
|
|
2024
Q4 | $59.4K | Buy |
19,540
+5,694
| +41% | +$17.3K | ﹤0.01% | 4929 |
|
|
2024
Q3 | $69K | Sell |
13,846
-40
| -0.3% | -$199 | ﹤0.01% | 4817 |
|
|
2024
Q2 | $81.2K | Buy |
13,886
+13,580
| +4,438% | +$79.4K | ﹤0.01% | 4702 |
|
|
2024
Q1 | $2.43K | Buy |
306
+5
| +2% | +$40 | ﹤0.01% | 5602 |
|
|
2023
Q4 | $1.76K | Buy |
301
+15
| +5% | +$87 | ﹤0.01% | 5681 |
|
|
2023
Q3 | $732 | Buy |
286
+206
| +258% | +$527 | ﹤0.01% | 5896 |
|
|
2023
Q2 | $200 | Buy |
80
+5
| +7% | +$13 | ﹤0.01% | 6397 |
|
|
2023
Q1 | $158 | Buy |
75
+2
| +3% | +$4 | ﹤0.01% | 6513 |
|
|
2022
Q4 | $113 | Buy |
73
+1
| +1% | +$2 | ﹤0.01% | 6438 |
|
|
2022
Q3 | $0 | Buy |
72
+26
| +57% | – | ﹤0.01% | 7012 |
|
|
2022
Q2 | $0 | Buy |
46
+5
| +12% | – | ﹤0.01% | 7141 |
|
|
2022
Q1 | $0 | Hold |
41
| – | – | ﹤0.01% | 7220 |
|
|
2021
Q4 | $0 | Hold |
41
| – | – | ﹤0.01% | 7205 |
|
|
2021
Q3 | $0 | Buy |
+41
| New | – | ﹤0.01% | 7122 |
|